Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check2 days agoChange DetectedThe record history now shows a new revision (v3.3.4) and the previous v3.3.3 entry has been removed, updating the version history without changing trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check52 days agoChange DetectedA new revision entry (v3.3.2) was added and an older revision (v3.2.0) was removed from the Record History. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check81 days agoChange DetectedThe Record History page shows a minor visual/layout update to how versions are displayed. There are no new versions or substantive changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check103 days agoChange DetectedUpdated the page to v3.2.0 and added a prominent government-status notice; the previous v3.1.0 reference was removed.SummaryDifference13%

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.